Stakeholder engagement
For decades Novo Nordisk has systematically been engaging with multiple stakeholders to address key areas of its business. Reaching out to stakeholders helps reconcile dilemmas and find common ground for more sustainable solutions. It also helps in monitoring trends that can affect its future business.
Stakeholder engagement is an integrated part of Novo Nordisk's business philosophy. Long-standing engagements with stakeholders are vital for building trust and understanding in a variety of issues. By involving stakeholders in the decision-making processes, decisions are better founded and solutions more likely to succeed.
Novo Nordisk's key stakeholders include people with diabetes and others who rely on the company’s products, customers (ie public healthcare providers and payers), employees, investors, suppliers and other business partners, neighbours, and key publics. For us, the patient is at the centre – and hence the ultimate stakeholder to which the company must hold itself accountable.
Memberships
Novo Nordisk seeks influence, learning and networking through several forms of engagement with stakeholders. One example of this is memberships of industry and business associations, advocacy organisations and affiliation with think tanks. For the full membership list see our latest annual report.
Partnerships
Partnerships are fundamental to the way in which we run our business. They help to build trust among our key stakeholders and to reach a better understanding of a variety of important issues. Partnerships also pave the way for more successful solutions to problems, concerns and challenges. For more information on how we define our partnerships and some of the recent highlights see our latest annual report.
